Results 181 to 190 of about 101,384 (314)

Moving Beyond the Hype in Extracellular Vesicle Therapy. [PDF]

JACC Basic Transl Sci
Marbán E.
europepmc   +1 more source

Global Meeting Plus (GMP)

, 2007
Global Meeting Plus (GMP) is a Web-based collaborative GroupWare application, which consists of chat-channel, whiteboard, database, communication security, and pillow-talking.
Polina Galkin, Sanzheng Qiao, Dan Yan
core  

Novel Organelle‐Based Intracellular Immunity With Mechanistic and Therapeutic Implications

Barrier Immunity, EarlyView.
A conceptual framework illustrating how PAMPs/DAMPs initiate barrier, innate, adaptive, and intracellular immune responses, with organelle‐based intracellular immunity serving as a central integrator linking metabolism, inflammatory signaling, and therapeutic interventions to restore immune homeostasis.
Keman Xu, Shih‐Yu Hung, Fatma Saaoud, Ying Shao, Yifan Lu, Juanjuan Liu, Bo Yuan, Haiyan Xiang, Hong Wang, Xiaofeng Yang   +9 more
wiley   +1 more source

Characterization of Recombinant GMPR from <i>Pocillopora damicornis</i> and Potential Mechanisms of Cold-Induced Metabolic Adaptation. [PDF]

Biology (Basel)
Kannan L, Jones J, Shivananda Murthy MH, Ghirlanda G, Klein-Seetharaman J.   +4 more
europepmc   +1 more source

Systemic aging fuels heart failure: Molecular mechanisms and therapeutic avenues

ESC Heart Failure, Volume 12, Issue 2, Page 1059-1080, April 2025.
Abstract Systemic aging influences various physiological processes and contributes to structural and functional decline in cardiac tissue. These alterations include an increased incidence of left ventricular hypertrophy, a decline in left ventricular diastolic function, left atrial dilation, atrial fibrillation, myocardial fibrosis and cardiac ...
Zhuyubing Fang, Umar Raza, Jia Song, Junyan Lu, Shun Yao, Xiaohong Liu, Wei Zhang, Shujuan Li   +7 more
wiley   +1 more source

Large-scale manufacturing of precisely patterned flexible soft tissue implants with high porosity. [PDF]

Biofabrication
Shabazz A, Christensen AP, Garvey D, Pallotta M, Vakili S, Farias S, Fisher JP.   +6 more
europepmc   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

Development of a GMMA-based candidate vaccine against invasive nontyphoidal <i>Salmonella</i> disease. [PDF]

Front Immunol
Citiulo F, Koeberling O, Rossi O, Cappelletti E, Giannelli C, Aruta MG, De Simone D, Pippi F, Ferhati X, De Felice A, Acquaviva A, Daniele A, De Luca F, Iannello G, Vitali CG, Necchi F, Martin LB, Berlanda Scorza F, Colucci AM, Canals R.   +19 more
europepmc   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

c-di-GMP-mediated pause behavior enables <i>Pseudomonas aeruginosa</i> navigation in porous environments. [PDF]

Appl Environ Microbiol
Zhang Z, Zhang R, Yuan J.
europepmc   +1 more source